Identification of a putative GH-releasing factor (GRF) batch as predominantly ovine CRF with a small quantity of human GRF.
The existence of discordant results regarding the effects of intracerebroventricular (icv) administration of GRF on GH secretion prompted a reexamination of the central actions of GRF and a detailed chemical characterization of the peptide designated as hpGRF-44-NH2. The icv injection of 10 micrograms rat (r) GRF to freely-moving rats caused an acute stimulation of GH release, whereas 10 micrograms of the putative hpGRF peptide icv continued to suppress spontaneous GH secretion. Through a series of biochemical and immunologic studies we demonstrate that peptide hpGRF-44-NH2, code number 92-81-5G-41-47, is predominantly ovine (o) CRF and also contains a small amount (3-5%) human (h) GRF-44-NH2. We conclude that the major effect of icv administered GRF, at high doses, is to stimulate GH release and that the central actions previously attributed to the hpGRF peptide are, in fact, due to the oCRF component of this compound.
Tannenbaum
G S
GS
van der Rest
M
M
Downs
T R
TR
Frohman
L A
LA
D000596:Amino Acids / Q000032:analysis; D000818:Animals; D001681:Biological Assay; D001786:Blood Glucose / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D003346:Corticotropin-Releasing Hormone / Q000032:analysis*; D013006:Growth Hormone / Q000378:metabolism; D013007:Growth Hormone-Releasing Hormone / Q000032:analysis* / Q000494:pharmacology; D006801:Humans; D010446:Peptide Fragments / Q000032:analysis; D051381:Rats; D012756:Sheep
D000596:Amino Acids; D001786:Blood Glucose; D010446:Peptide Fragments; D013006:Growth Hormone; D003346:Corticotropin-Releasing Hormone; D013007:Growth Hormone-Releasing Hormone